99 related articles for article (PubMed ID: 2213558)
1. Thromboxane A2-mimetics are potent microvascular permeability factors in the conjunctiva.
Woodward DF; Nieves AL; Williams LS
J Pharmacol Exp Ther; 1990 Oct; 255(1):23-7. PubMed ID: 2213558
[TBL] [Abstract][Full Text] [Related]
2. AGN 191976: a novel thromboxane A2-mimetic with ocular hypotensive properties.
Krauss AH; Woodward DF; Chen J; Gibson LL; Lai RK; Protzman CE; Shan T; Williams LS; Gac TS; Burk RM
J Ocul Pharmacol Ther; 1995; 11(3):203-12. PubMed ID: 8590251
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
Krauss AH; Woodward DF; Burk RM; Gac TS; Gibson LL; Protzman CE; Abbass F; Marshall K; Senior J
J Ocul Pharmacol Ther; 1997 Aug; 13(4):303-12. PubMed ID: 9261766
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent mediation of leukotriene D4-induced airway microvascular leakage and bronchoconstriction in the guinea pig.
Bochnowicz S; Underwood DC
Prostaglandins Leukot Essent Fatty Acids; 1995 Jun; 52(6):403-11. PubMed ID: 7644563
[TBL] [Abstract][Full Text] [Related]
5. Influence of SQ 30741 on thromboxane receptor-mediated responses in the feline pulmonary vascular bed.
McMahon TJ; Hood JS; Nossaman BD; Ibrahim IN; Feng CJ; Kadowitz PJ
J Appl Physiol (1985); 1991 Nov; 71(5):2012-8. PubMed ID: 1837015
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
Bertolino F; Valentin JP; Maffre M; Grelac F; Bessac AM; Maclouf J; Delhon A; Lévy-Toledano S; Patoiseau JF; Colpaert FC
Br J Pharmacol; 1995 May; 115(1):210-6. PubMed ID: 7647979
[TBL] [Abstract][Full Text] [Related]
7. Involvement of thromboxane A2 and histamine in experimental allergic rhinitis of guinea pigs.
Yamasaki M; Matsumoto T; Fukuda S; Nakayama T; Nagaya H; Ashida Y
J Pharmacol Exp Ther; 1997 Mar; 280(3):1471-9. PubMed ID: 9067337
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene D4- and prostaglandin F2 alpha-induced airflow obstruction and airway plasma exudation in guinea-pig: role of thromboxane and its receptor.
Arakawa H; Lötvall J; Kawikova I; Löfdahl CG; Skoogh BE
Br J Pharmacol; 1993 Sep; 110(1):127-32. PubMed ID: 8220872
[TBL] [Abstract][Full Text] [Related]
9. TxA2 receptor activation elicits organ-specific increases in microvascular permeability in the rat.
Bertolino F; Valentin JP; Maffre M; Bessac AM; John GW
Am J Physiol; 1995 Feb; 268(2 Pt 2):R366-74. PubMed ID: 7864230
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane induced red blood cell lysis.
Brezinski ME; Lefer DJ; Bowker B; Lefer AM
Prostaglandins; 1987 Jan; 33(1):75-84. PubMed ID: 3588967
[TBL] [Abstract][Full Text] [Related]
11. Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist.
Bertolino F; Valentin JP; Maffre M; Jover B; Bessac AM; John GW
J Pharmacol Exp Ther; 1994 Feb; 268(2):747-52. PubMed ID: 8113986
[TBL] [Abstract][Full Text] [Related]
12. Renal vasoconstriction with U-46,619; role of arachidonate metabolites.
Wilcox CS; Folger WH; Welch WJ
J Am Soc Nephrol; 1994 Oct; 5(4):1120-4. PubMed ID: 7849252
[TBL] [Abstract][Full Text] [Related]
13. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
Karasawa A; Shirakura S; Higo K; Kubo K
Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
[TBL] [Abstract][Full Text] [Related]
15. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
16. [Effects of thromboxane A2 and prostaglandin I2 on the release of chemical mediators from human peripheral leukocytes].
Tanaka Y; Imai T; Horikoshi S; Kurokawa M; Kimura T; Matsuura T; Idaira K; Adachi M; Takahashi T
Arerugi; 1993 Nov; 42(11):1677-82. PubMed ID: 7506521
[TBL] [Abstract][Full Text] [Related]
17. Daltroban blocks thromboxane responses in the pulmonary vascular bed of the cat.
Hood JS; Nossaman BD; Ibrahim IN; McMahon TJ; Babycos CR; Kadowitz PJ
J Appl Physiol (1985); 1992 Jun; 72(6):2305-10. PubMed ID: 1385804
[TBL] [Abstract][Full Text] [Related]
18. FTIR spectral study of intramolecular hydrogen bonding in thromboxane A2 receptor agonist (U-46619), prostaglandin (PG)E2, PGD2, PGF2 alpha, prostacyclin receptor agonist (carbacyclin), and their related compounds in dilute CCl4 solution: structure-activity relationships.
Takasuka M; Kishi M; Yamakawa M
J Med Chem; 1994 Jan; 37(1):47-56. PubMed ID: 8289201
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary pharmacology of DT-TX 30 SE, a potent selective combined thromboxane synthetase inhibitor and receptor antagonist, in guinea pigs.
Meade CJ; Muacevic G; Ward P; Soyka R
Jpn J Pharmacol; 1996 Jun; 71(2):119-27. PubMed ID: 8835638
[TBL] [Abstract][Full Text] [Related]
20. [Inhibitory effects of AA-2414, a thromboxane (Tx) A2 receptor antagonist, on U-46619-, prostaglandin (PG) D2- and 9 alpha, 11 beta PGF2-induced contractions of guinea pig tracheas and isolated human bronchi].
Itoh Y; Shindoh J; Horiba M; Kohno S; Ohata K; Ashida Y; Takagi K
Arerugi; 1993 Nov; 42(11):1670-6. PubMed ID: 8279967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
